HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-JUL-11 3SXR
TITLE CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEX WITH
TITLE 2 DASATINIB
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: UNP RESIDUES 411-675;
COMPND 5 SYNONYM: BONE MARROW TYROSINE KINASE GENE IN CHROMOSOME X PROTEIN,
COMPND 6 EPITHELIAL AND ENDOTHELIAL TYROSINE KINASE, ETK, NTK38;
COMPND 7 EC: 2.7.10.2;
COMPND 8 ENGINEERED: YES;
COMPND 9 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: AGMX1, ATK, BMX, BPK, BTK;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108;
SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9;
SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS
KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.SACK,J.MUCKELBAUER
REVDAT 3 28-FEB-24 3SXR 1 REMARK SEQADV
REVDAT 2 30-NOV-11 3SXR 1 JRNL
REVDAT 1 21-SEP-11 3SXR 0
JRNL AUTH J.MUCKELBAUER,J.S.SACK,N.AHMED,J.BURKE,C.Y.CHANG,M.GAO,
JRNL AUTH 2 J.TINO,D.XIE,A.J.TEBBEN
JRNL TITL X-RAY CRYSTAL STRUCTURE OF BONE MARROW KINASE IN THE X
JRNL TITL 2 CHROMOSOME: A TEC FAMILY KINASE.
JRNL REF CHEM.BIOL.DRUG DES. V. 78 739 2011
JRNL REFN ISSN 1747-0277
JRNL PMID 21883956
JRNL DOI 10.1111/J.1747-0285.2011.01230.X
REMARK 2
REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.1
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.22
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 3 NUMBER OF REFLECTIONS : 26844
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.189
REMARK 3 R VALUE (WORKING SET) : 0.187
REMARK 3 FREE R VALUE : 0.231
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020
REMARK 3 FREE R VALUE TEST SET COUNT : 1348
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 13
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.50
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.64
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2910
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2120
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2760
REMARK 3 BIN R VALUE (WORKING SET) : 0.2103
REMARK 3 BIN FREE R VALUE : 0.2437
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.15
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 150
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4242
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 81
REMARK 3 SOLVENT ATOMS : 212
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 37.83
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.02
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -7.69850
REMARK 3 B22 (A**2) : 5.60690
REMARK 3 B33 (A**2) : 2.09150
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.267
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.323
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.880
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 4436 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 5987 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1557 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 94 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 674 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 4436 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 524 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 5097 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.12
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.42
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.42
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3SXR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-JUL-11.
REMARK 100 THE DEPOSITION ID IS D_1000066783.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 27-SEP-08
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SLS
REMARK 200 BEAMLINE : X06DA
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26852
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5
REMARK 200 DATA REDUNDANCY : 4.700
REMARK 200 R MERGE (I) : 0.10900
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6
REMARK 200 DATA REDUNDANCY IN SHELL : 4.40
REMARK 200 R MERGE FOR SHELL (I) : 0.53100
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.000
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 53.95
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.34000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 84.64500
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.56500
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 84.64500
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.34000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.56500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 4270 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 23660 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -69.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 426
REMARK 465 GLN A 427
REMARK 465 PHE A 428
REMARK 465 GLY A 429
REMARK 465 LYS A 672
REMARK 465 ASP A 673
REMARK 465 LYS A 674
REMARK 465 HIS A 675
REMARK 465 GLY B 424
REMARK 465 SER B 425
REMARK 465 GLY B 426
REMARK 465 GLN B 427
REMARK 465 PHE B 428
REMARK 465 GLY B 429
REMARK 465 LYS B 672
REMARK 465 ASP B 673
REMARK 465 LYS B 674
REMARK 465 HIS B 675
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ASP A 594 C - N - CA ANGL. DEV. = 16.5 DEGREES
REMARK 500 ASP B 594 C - N - CA ANGL. DEV. = 15.8 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 MET A 410 -29.18 -142.02
REMARK 500 ASP A 536 52.59 -146.30
REMARK 500 LEU A 537 98.34 -69.15
REMARK 500 ARG A 670 84.93 87.45
REMARK 500 HIS B 409 20.82 -145.17
REMARK 500 LEU B 420 -65.62 -107.31
REMARK 500 ASP B 536 53.11 -146.36
REMARK 500 LEU B 537 98.59 -69.43
REMARK 500 ASP B 614 -83.20 -2.40
REMARK 500 ARG B 670 109.05 129.81
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1N1 A 1
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 676
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1N1 B 2
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 676
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 3
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3SXS RELATED DB: PDB
DBREF 3SXR A 411 675 UNP P51813 BMX_HUMAN 411 675
DBREF 3SXR B 411 675 UNP P51813 BMX_HUMAN 411 675
SEQADV 3SXR GLY A 408 UNP P51813 EXPRESSION TAG
SEQADV 3SXR HIS A 409 UNP P51813 EXPRESSION TAG
SEQADV 3SXR MET A 410 UNP P51813 EXPRESSION TAG
SEQADV 3SXR LYS A 432 UNP P51813 GLN 432 ENGINEERED MUTATION
SEQADV 3SXR MET A 611 UNP P51813 GLN 611 ENGINEERED MUTATION
SEQADV 3SXR THR A 617 UNP P51813 ASP 617 ENGINEERED MUTATION
SEQADV 3SXR GLU A 620 UNP P51813 GLN 620 ENGINEERED MUTATION
SEQADV 3SXR GLY B 408 UNP P51813 EXPRESSION TAG
SEQADV 3SXR HIS B 409 UNP P51813 EXPRESSION TAG
SEQADV 3SXR MET B 410 UNP P51813 EXPRESSION TAG
SEQADV 3SXR LYS B 432 UNP P51813 GLN 432 ENGINEERED MUTATION
SEQADV 3SXR MET B 611 UNP P51813 GLN 611 ENGINEERED MUTATION
SEQADV 3SXR THR B 617 UNP P51813 ASP 617 ENGINEERED MUTATION
SEQADV 3SXR GLU B 620 UNP P51813 GLN 620 ENGINEERED MUTATION
SEQRES 1 A 268 GLY HIS MET GLU LEU LYS ARG GLU GLU ILE THR LEU LEU
SEQRES 2 A 268 LYS GLU LEU GLY SER GLY GLN PHE GLY VAL VAL LYS LEU
SEQRES 3 A 268 GLY LYS TRP LYS GLY GLN TYR ASP VAL ALA VAL LYS MET
SEQRES 4 A 268 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE PHE GLN
SEQRES 5 A 268 GLU ALA GLN THR MET MET LYS LEU SER HIS PRO LYS LEU
SEQRES 6 A 268 VAL LYS PHE TYR GLY VAL CYS SER LYS GLU TYR PRO ILE
SEQRES 7 A 268 TYR ILE VAL THR GLU TYR ILE SER ASN GLY CYS LEU LEU
SEQRES 8 A 268 ASN TYR LEU ARG SER HIS GLY LYS GLY LEU GLU PRO SER
SEQRES 9 A 268 GLN LEU LEU GLU MET CYS TYR ASP VAL CYS GLU GLY MET
SEQRES 10 A 268 ALA PHE LEU GLU SER HIS GLN PHE ILE HIS ARG ASP LEU
SEQRES 11 A 268 ALA ALA ARG ASN CYS LEU VAL ASP ARG ASP LEU CYS VAL
SEQRES 12 A 268 LYS VAL SER ASP PHE GLY MET THR ARG TYR VAL LEU ASP
SEQRES 13 A 268 ASP GLN TYR VAL SER SER VAL GLY THR LYS PHE PRO VAL
SEQRES 14 A 268 LYS TRP SER ALA PRO GLU VAL PHE HIS TYR PHE LYS TYR
SEQRES 15 A 268 SER SER LYS SER ASP VAL TRP ALA PHE GLY ILE LEU MET
SEQRES 16 A 268 TRP GLU VAL PHE SER LEU GLY LYS MET PRO TYR ASP LEU
SEQRES 17 A 268 TYR THR ASN SER GLU VAL VAL LEU LYS VAL SER GLN GLY
SEQRES 18 A 268 HIS ARG LEU TYR ARG PRO HIS LEU ALA SER ASP THR ILE
SEQRES 19 A 268 TYR GLN ILE MET TYR SER CYS TRP HIS GLU LEU PRO GLU
SEQRES 20 A 268 LYS ARG PRO THR PHE GLN GLN LEU LEU SER SER ILE GLU
SEQRES 21 A 268 PRO LEU ARG GLU LYS ASP LYS HIS
SEQRES 1 B 268 GLY HIS MET GLU LEU LYS ARG GLU GLU ILE THR LEU LEU
SEQRES 2 B 268 LYS GLU LEU GLY SER GLY GLN PHE GLY VAL VAL LYS LEU
SEQRES 3 B 268 GLY LYS TRP LYS GLY GLN TYR ASP VAL ALA VAL LYS MET
SEQRES 4 B 268 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE PHE GLN
SEQRES 5 B 268 GLU ALA GLN THR MET MET LYS LEU SER HIS PRO LYS LEU
SEQRES 6 B 268 VAL LYS PHE TYR GLY VAL CYS SER LYS GLU TYR PRO ILE
SEQRES 7 B 268 TYR ILE VAL THR GLU TYR ILE SER ASN GLY CYS LEU LEU
SEQRES 8 B 268 ASN TYR LEU ARG SER HIS GLY LYS GLY LEU GLU PRO SER
SEQRES 9 B 268 GLN LEU LEU GLU MET CYS TYR ASP VAL CYS GLU GLY MET
SEQRES 10 B 268 ALA PHE LEU GLU SER HIS GLN PHE ILE HIS ARG ASP LEU
SEQRES 11 B 268 ALA ALA ARG ASN CYS LEU VAL ASP ARG ASP LEU CYS VAL
SEQRES 12 B 268 LYS VAL SER ASP PHE GLY MET THR ARG TYR VAL LEU ASP
SEQRES 13 B 268 ASP GLN TYR VAL SER SER VAL GLY THR LYS PHE PRO VAL
SEQRES 14 B 268 LYS TRP SER ALA PRO GLU VAL PHE HIS TYR PHE LYS TYR
SEQRES 15 B 268 SER SER LYS SER ASP VAL TRP ALA PHE GLY ILE LEU MET
SEQRES 16 B 268 TRP GLU VAL PHE SER LEU GLY LYS MET PRO TYR ASP LEU
SEQRES 17 B 268 TYR THR ASN SER GLU VAL VAL LEU LYS VAL SER GLN GLY
SEQRES 18 B 268 HIS ARG LEU TYR ARG PRO HIS LEU ALA SER ASP THR ILE
SEQRES 19 B 268 TYR GLN ILE MET TYR SER CYS TRP HIS GLU LEU PRO GLU
SEQRES 20 B 268 LYS ARG PRO THR PHE GLN GLN LEU LEU SER SER ILE GLU
SEQRES 21 B 268 PRO LEU ARG GLU LYS ASP LYS HIS
HET 1N1 A 1 33
HET SO4 A 676 5
HET 1N1 B 2 33
HET SO4 B 676 5
HET SO4 B 3 5
HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)
HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-
HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE
HETNAM SO4 SULFATE ION
HETSYN 1N1 DASATINIB
FORMUL 3 1N1 2(C22 H26 CL N7 O2 S)
FORMUL 4 SO4 3(O4 S 2-)
FORMUL 8 HOH *212(H2 O)
HELIX 1 1 LYS A 413 GLU A 415 5 3
HELIX 2 2 SER A 453 LEU A 467 1 15
HELIX 3 3 CYS A 496 GLY A 505 1 10
HELIX 4 4 LYS A 506 LEU A 508 5 3
HELIX 5 5 GLU A 509 HIS A 530 1 22
HELIX 6 6 ALA A 538 ARG A 540 5 3
HELIX 7 7 PRO A 575 SER A 579 5 5
HELIX 8 8 ALA A 580 PHE A 587 1 8
HELIX 9 9 LYS A 592 SER A 607 1 16
HELIX 10 10 THR A 617 GLY A 628 1 12
HELIX 11 11 SER A 638 CYS A 648 1 11
HELIX 12 12 LEU A 652 ARG A 656 5 5
HELIX 13 13 THR A 658 GLU A 667 1 10
HELIX 14 14 PRO A 668 ARG A 670 5 3
HELIX 15 15 LYS B 413 GLU B 415 5 3
HELIX 16 16 SER B 453 LEU B 467 1 15
HELIX 17 17 CYS B 496 GLY B 505 1 10
HELIX 18 18 LYS B 506 LEU B 508 5 3
HELIX 19 19 GLU B 509 HIS B 530 1 22
HELIX 20 20 ALA B 538 ARG B 540 5 3
HELIX 21 21 PRO B 575 SER B 579 5 5
HELIX 22 22 ALA B 580 HIS B 585 1 6
HELIX 23 23 LYS B 592 SER B 607 1 16
HELIX 24 24 THR B 617 GLY B 628 1 12
HELIX 25 25 SER B 638 CYS B 648 1 11
HELIX 26 26 LEU B 652 ARG B 656 5 5
HELIX 27 27 THR B 658 GLU B 671 1 14
SHEET 1 A 5 ILE A 417 GLY A 424 0
SHEET 2 A 5 VAL A 431 TRP A 436 -1 O LEU A 433 N LYS A 421
SHEET 3 A 5 TYR A 440 ILE A 447 -1 O TYR A 440 N TRP A 436
SHEET 4 A 5 ILE A 485 GLU A 490 -1 O ILE A 487 N LYS A 445
SHEET 5 A 5 PHE A 475 CYS A 479 -1 N GLY A 477 O VAL A 488
SHEET 1 B 2 PHE A 532 HIS A 534 0
SHEET 2 B 2 THR A 558 TYR A 560 -1 O ARG A 559 N ILE A 533
SHEET 1 C 2 CYS A 542 VAL A 544 0
SHEET 2 C 2 VAL A 550 VAL A 552 -1 O LYS A 551 N LEU A 543
SHEET 1 D 2 TYR A 566 SER A 568 0
SHEET 2 D 2 LYS A 588 SER A 590 -1 O TYR A 589 N VAL A 567
SHEET 1 E 5 ILE B 417 GLU B 422 0
SHEET 2 E 5 VAL B 431 TRP B 436 -1 O LEU B 433 N LEU B 420
SHEET 3 E 5 TYR B 440 ILE B 447 -1 O TYR B 440 N TRP B 436
SHEET 4 E 5 ILE B 485 GLU B 490 -1 O ILE B 487 N LYS B 445
SHEET 5 E 5 PHE B 475 CYS B 479 -1 N GLY B 477 O VAL B 488
SHEET 1 F 2 PHE B 532 HIS B 534 0
SHEET 2 F 2 THR B 558 TYR B 560 -1 O ARG B 559 N ILE B 533
SHEET 1 G 2 CYS B 542 VAL B 544 0
SHEET 2 G 2 VAL B 550 VAL B 552 -1 O LYS B 551 N LEU B 543
SHEET 1 H 2 TYR B 566 SER B 568 0
SHEET 2 H 2 LYS B 588 SER B 590 -1 O TYR B 589 N VAL B 567
CISPEP 1 TYR A 483 PRO A 484 0 -4.30
CISPEP 2 TYR B 483 PRO B 484 0 -4.23
SITE 1 AC1 14 LEU A 423 VAL A 431 ALA A 443 LYS A 445
SITE 2 AC1 14 ILE A 487 THR A 489 GLU A 490 TYR A 491
SITE 3 AC1 14 ILE A 492 SER A 493 GLY A 495 SER A 553
SITE 4 AC1 14 PHE A 555 LEU B 420
SITE 1 AC2 9 HOH A 81 HOH A 115 HOH A 148 TYR A 586
SITE 2 AC2 9 SER A 607 LYS A 610 TYR A 632 PRO A 634
SITE 3 AC2 9 HIS A 635
SITE 1 AC3 15 HOH B 116 HOH B 157 LEU B 423 VAL B 431
SITE 2 AC3 15 ALA B 443 LYS B 445 ILE B 487 THR B 489
SITE 3 AC3 15 GLU B 490 TYR B 491 ILE B 492 SER B 493
SITE 4 AC3 15 GLY B 495 SER B 553 PHE B 555
SITE 1 AC4 7 VAL A 567 SER A 568 HOH B 227 GLY B 408
SITE 2 AC4 7 HIS B 409 MET B 410 GLU B 411
SITE 1 AC5 4 LYS B 610 TYR B 632 PRO B 634 HIS B 635
CRYST1 58.680 67.130 169.290 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017042 0.000000 0.000000 0.00000
SCALE2 0.000000 0.014896 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005907 0.00000